ID
21064
Description
Rituximab, Bortezomib, Doxorubicin, Dexamethasone, and Chlorambucil Patients With Mantle Cell Lymphoma; ODM derived from: https://clinicaltrials.gov/show/NCT00740415
Link
https://clinicaltrials.gov/show/NCT00740415
Keywords
Versions (1)
- 4/7/17 4/7/17 -
Uploaded on
April 7, 2017
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Lymphoma NCT00740415
Eligibility Lymphoma NCT00740415
- StudyEvent: Eligibility
Similar models
Eligibility Lymphoma NCT00740415
- StudyEvent: Eligibility
C0851140 (UMLS CUI [2])
C0007117 (UMLS CUI [3])
C0019196 (UMLS CUI [2])
C0232804 (UMLS CUI [2])
C1254358 (UMLS CUI [3,1])
C0005953 (UMLS CUI [3,2])
C1514463 (UMLS CUI [1,2])
No comments